FDA Clarifies Software Link In Abbott COVID-19 Lab Test Recall
Executive Summary
The recall is related to the software’s mixing parameters, which may cause false positives if test samples contaminate each other.
You may also be interested in...
Abbott COVID-19 Lab Test Recall Deemed High-Risk Class I
The recall is related to potential false positives that may occur if a genuine positive test sample overflows into an adjacent sample that would have otherwise tested negative.
Company Faces False Claims Charges For Disposable Rectal Probe Reuse
The Prometheus Group reportedly told health care providers that they could reuse probes that were part of its pelvic floor therapy system on multiple patients by covering them with a condom or the finger of a rubber glove.
Federal Small Business Research Grant Programs At Risk Of Expiration, AdvaMed Says
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs will shut down on 30 September if Congress doesn’t act to renew them – but some US senators say the programs are wasteful and may funnel research overseas.